FibroGen Inc (FGEN)

Mexico
Currency in MXN
9.790
+0.290(+3.05%)
Delayed Data
FGEN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
9.7909.790
52 wk Range
6.33037.550
Key Statistics
Edit
Bid/Ask
10.00 / 10.30
Prev. Close
9.5
Open
9.79
Day's Range
9.79-9.79
52 wk Range
6.33-37.55
Volume
52
Average Volume (3m)
485
1-Year Change
-74.87%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FGEN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

FibroGen Inc Company Profile

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Employees
486
Market
Mexico

Compare FGEN to Peers and Sector

Metrics to compare
FGEN
Peers
Sector
Relationship
P/E Ratio
−0.4x−3.1x−0.6x
PEG Ratio
−0.01−0.080.00
Price/Book
−0.2x2.2x2.6x
Price / LTM Sales
0.3x7.0x3.1x
Upside (Analyst Target)
-155.8%51.8%
Fair Value Upside
Unlock31.9%8.3%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the FibroGen Inc (FGEN) Stock Price Today?

The FibroGen Inc stock price today is 9.79.

What Stock Exchange Does FibroGen Inc Trade On?

FibroGen Inc is listed and trades on the Mexico stock exchange.

What Is the Stock Symbol for FibroGen Inc?

The stock symbol for FibroGen Inc is "FGEN."

What Is the FibroGen Inc Market Cap?

As of today, FibroGen Inc market cap is 941.73M.

What is FibroGen Inc Earnings Per Share?

The FibroGen Inc EPS is -1.22.

From a Technical Analysis Perspective, Is FGEN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.